Literature DB >> 6380897

Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis.

F Wafin, E Valindas, E Wuolijoki.   

Abstract

The efficacy and tolerability of 100 mg suppositories of diclofenac sodium (Voltaren) and indomethacin were investigated in relieving symptoms of rheumatoid arthritis. Thirty patients were included in a double-blind, cross-over study for two weeks - six days with diclofenac suppositories, following two days with placebo and six days with indomethacin. Diclofenac sodium and indomethacin were given in random order. Both treatments improved the status of the disease as compared with the situation before the treatment (p less than 0.01). No statistically significant difference was found between the efficacy of indomethacin and diclofenac sodium, as regards both the doctor's and the patient's global assessments. The two treatments were equally well tolerated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380897     DOI: 10.1007/bf02715698

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  2 in total

1.  Diclofenac suppositories in osteoarthrosis. A double-blind comparison with indomethacin.

Authors:  L Ehmann; J M Tyberghein
Journal:  Practitioner       Date:  1981-05

Review 2.  Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

  2 in total
  2 in total

Review 1.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 2.  Application of liposomes in treatment of rheumatoid arthritis: quo vadis.

Authors:  Bhupinder Kapoor; Sachin Kumar Singh; Monica Gulati; Reena Gupta; Yogyata Vaidya
Journal:  ScientificWorldJournal       Date:  2014-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.